Insider Trading April 3, 2026

Hershey director sells $26,161 in shares under prearranged plan

Cordel Robbin-Coker disposed of 129 shares; analysts maintain mixed views as valuation questions persist

By Avery Klein HSY
Hershey director sells $26,161 in shares under prearranged plan
HSY

Cordel Robbin-Coker, a member of Hershey Co.'s board, sold 129 shares on April 2, 2026, for $202.80 each under a Rule 10b5-1 plan, netting $26,161. The transaction leaves Robbin-Coker with 1,507.737 direct shares. The move comes amid analyst debate over Hershey's valuation after management outlined 15%-20% EPS growth targets to 2027 and initial guidance for fiscal 2027 and 2028.

Key Points

  • Cordel Robbin-Coker sold 129 Hershey shares on April 2, 2026, under a Rule 10b5-1 plan for $202.80 each, totaling $26,161; post-sale ownership is 1,507.737 shares.
  • Hershey shares trade at $206.19, up 27% over the past year, with a reported P/E of 47.41 and a market cap of $41.79 billion; dividend yield is 2.82% and dividends have been paid for 56 consecutive years.
  • Management projects 15%-20% EPS growth by 2027 and provided initial guidance for fiscal 2027 and 2028; analysts are split on valuation with Piper Sandler Overweight ($249 PT), UBS Neutral ($215 PT), DA Davidson $230 PT, Stifel Hold ($230 PT) and TD Cowen Hold ($210 PT).

Key transaction details

Cordel Robbin-Coker, a director at Hershey Co (NYSE:HSY), sold 129 shares of the company’s common stock on April 2, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The sale price was $202.80 per share, producing a total transaction value of $26,161.

The filing states the sale was carried out under a Rule 10b5-1 trading arrangement that Robbin-Coker adopted on August 1, 2025. After the trade closed, Robbin-Coker is recorded as directly owning 1,507.737 shares of Hershey.


Market context and valuation

Hershey's shares are trading at $206.19, representing a 27% gain over the past 12 months. InvestingPro analysis cited in the filing indicates the stock appears overvalued at current levels, with a price-to-earnings ratio of 47.41. The company carries a market capitalization of $41.79 billion and yields 2.82% in dividends. Hershey has maintained dividend payments for 56 consecutive years.


Corporate outlook and analyst positioning

Management shared an optimistic forecast during the company’s Investor Day presentation at the New York Stock Exchange, outlining a target for earnings per share growth of 15% to 20% by 2027. That presentation also included the company’s initial guidance for fiscal years 2027 and 2028.

Brokerage and research firms remain divided on Hershey's valuation and outlook. Piper Sandler reiterated an Overweight rating and held a $249 price target, citing the company’s innovation strategy and its growth investments. By contrast, UBS trimmed its price target to $215 from $236 but kept a Neutral rating. DA Davidson lowered its target to $230 from $243, attributing the change to valuation concerns while leaving earnings estimates unchanged. Stifel and TD Cowen both maintained Hold ratings, with price targets of $230 and $210 respectively. These positions reflect a view among analysts that, although Hershey has an established growth strategy, questions persist around current valuation.


What the filing shows and what it does not

The Form 4 provides the concrete mechanics of the trade - share count, price, plan type and resulting ownership - but does not assert any motive beyond the fact the sale was executed under a prearranged 10b5-1 plan. The document also does not alter the company’s reported guidance or analysts’ published estimates; it simply records an insider disposition in the context of the broader market and analyst commentary outlined above.

Bottom line

This filing records a modest insider sale by a board member executed within a preexisting plan. The transaction occurs against a backdrop of management's multi-year EPS targets and mixed analyst sentiment focused on valuation.

Risks

  • Valuation concerns - multiple analysts cited valuation as the reason for lowered price targets, which could pressure equity performance; this affects the equities and consumer staples sectors.
  • Guidance execution risk - management’s 15%-20% EPS growth target to 2027 is forward-looking and subject to execution risk, impacting investor expectations in consumer staples and broader market earnings forecasts.
  • Analyst divergence - differing price targets and ratings create uncertainty for investors assessing entry points and risk-reward, affecting market sentiment in the stock and peer coverage in the consumer goods sector.

More from Insider Trading

Willis Lease Finance CEO Sells $590,067 in Shares as Company Undertakes Financing Moves Apr 3, 2026 Apple SVP Deirdre O’Brien Disposes $7.6M in AAPL Shares Amid Multiple Corporate Developments Apr 3, 2026 PubMatic CEO Disposes of $408K in Stock After Exercising Options Apr 3, 2026 Astera Labs GC Executes $1.07M Sale Under Rule 10b5-1; Company Posts Strong Q4 2025 Results Apr 3, 2026 Tim Cook Sells $16.5 Million in Apple Stock Amid RSU Vesting and Option Exercises Apr 3, 2026